Teva Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Teva Pharma (TEVA) Tops Q1 EPS by 2c, Revenues Miss
May 2, 2019 7:02 AM EDTTeva Pharma (NYSE: TEVA) reported Q1 EPS of $0.60, $0.02 better than the analyst estimate of $0.58. Revenue for the quarter came in at $4.3 billion versus the consensus estimate of $4.38 billion.
Revenues of $4.3 billionGAAP diluted loss per share of $0.10Non-GAAP diluted EPS of $0.60Free cash flow of $360... More